Researchers at Federal Research Center Publish New Study Findings on Non-Hodgkin Lymphoma (Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with...).

Antineoplastic Monoclonal Antibodies, Antineoplastics, Antirheumatics, Biotechnology, CD20 Monoclonal Antibodies, Cancer, Drugs and Therapies, Health and Medicine, Hematology, Immunologic Agents, Immunoproliferative Disorders, Lymphatic Diseases and Conditions, Lymphoma, Lymphoproliferative Disorders, Medical Devices, Monoclonal Antibodies, Non-Hodgkin Lymphoma, Oncology, Pharmaceuticals, Rituximab Therapy, Therapy, Tyrosine Kinase Inhibitors Four patients have died within first 3 weeks of therapy, 2 were primary refractory patients and 55 patients have achieved complete remissions. Keywords: Antineoplastic Monoclonal Antibodies; Antineoplastics; Antirheumatics; Biotechnology; CD20 Monoclonal Antibodies; Cancer; Drugs and Therapies; Health and Medicine; Hematology; Immunologic Agents; Immunoproliferative Disorders; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Medical Devices; Monoclonal Antibodies; Non-Hodgkin Lymphoma; Oncology; Pharmaceuticals; Rituximab Therapy; Therapy; Tyrosine Kinase Inhibitors EN Antineoplastic Monoclonal Antibodies Antineoplastics Antirheumatics Biotechnology CD20 Monoclonal Antibodies Cancer Drugs and Therapies Health and Medicine Hematology Immunologic Agents Immunoproliferative Disorders Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Medical Devices Monoclonal Antibodies Non-Hodgkin Lymphoma Oncology Pharmaceuticals Rituximab Therapy Therapy Tyrosine Kinase Inhibitors 1778 1778 1 04/17/23 20230418 NES 230418 2023 APR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Data detailed on non-hodgkin lymphoma have been presented. [Extracted from the article]